Literature DB >> 22760413

Why multidisciplinary clinics should be the standard for treating chronic kidney disease.

Guido Filler, Steven E Lipshultz.   

Abstract

In adults, strong evidence indicates that slowing progression of chronic kidney disease (CKD) requires an integrated, multidisciplinary approach. In children, however, this approach has not been studied. This editorial commentary to the study by Ajarmeh et al in this volume of Pediatric Nephrology highlights how a dedicated, multidisciplinary team of physicians, nurses, pharmacists, dieticians, social workders and clinic data managers slowed the progression of CKD in children to a remarkable degree. We discuss the strengths and limitations of the study and its cost implications, as well as the issue of determining the optional complement of physicians and allied health care professionals in such clinics. Our calculations indicate that the additional costs of such clinics would be recovered in one year, even if the progession of CKD were to be delayed by 1 year in only 2% of affected children. Here, we call on the international pediatric nephrology community to establish guidelines for forming multidisciplinary clinics throughout the world.

Entities:  

Mesh:

Year:  2012        PMID: 22760413     DOI: 10.1007/s00467-012-2236-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  31 in total

1.  Variability of the pediatric subspecialty workforce in Canada.

Authors:  Guido Filler; Bruno Piedboeuf
Journal:  J Pediatr       Date:  2010-06-17       Impact factor: 4.406

2.  Cardiotoxicity after childhood cancer: beginning with the end in mind.

Authors:  Steven E Lipshultz; M Jacob Adams
Journal:  J Clin Oncol       Date:  2010-02-08       Impact factor: 44.544

3.  NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation-Dialysis Outcomes Quality Initiative.

Authors: 
Journal:  Am J Kidney Dis       Date:  1997-10       Impact factor: 8.860

Review 4.  Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.

Authors:  C Black; P Sharma; G Scotland; K McCullough; D McGurn; L Robertson; N Fluck; A MacLeod; P McNamee; G Prescott; C Smith
Journal:  Health Technol Assess       Date:  2010-04       Impact factor: 4.014

5.  Prevalence of complications in children with chronic kidney disease according to KDOQI.

Authors:  H Wong; K Mylrea; J Feber; A Drukker; G Filler
Journal:  Kidney Int       Date:  2006-06-21       Impact factor: 10.612

6.  The impact of self-management support on the progression of chronic kidney disease--a prospective randomized controlled trial.

Authors:  Sue-Hsien Chen; Yun-Fang Tsai; Chiao-Yin Sun; I-Wen Wu; Chin-Chan Lee; Mai-Szu Wu
Journal:  Nephrol Dial Transplant       Date:  2011-03-17       Impact factor: 5.992

7.  Cost savings of home nocturnal versus conventional in-center hemodialysis.

Authors:  Philip A McFarlane; Andreas Pierratos; Donald A Redelmeier
Journal:  Kidney Int       Date:  2002-12       Impact factor: 10.612

8.  The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes.

Authors:  Bryan M Curtis; Pietro Ravani; F Malberti; Fiona Kennett; Paul A Taylor; Ognjenka Djurdjev; Adeera Levin
Journal:  Nephrol Dial Transplant       Date:  2004-12-07       Impact factor: 5.992

9.  Association between residence location and likelihood of transplantation among pediatric dialysis patients.

Authors:  Susan M Samuel; Brenda Hemmelgarn; Alberto Nettel-Aguirre; Bethany Foster; Andrea Soo; R Todd Alexander; Marcello Tonelli
Journal:  Pediatr Transplant       Date:  2012-04-10

10.  Strict blood-pressure control and progression of renal failure in children.

Authors:  Elke Wühl; Antonella Trivelli; Stefano Picca; Mieczyslaw Litwin; Amira Peco-Antic; Aleksandra Zurowska; Sara Testa; Augustina Jankauskiene; Sevinc Emre; Alberto Caldas-Afonso; Ali Anarat; Patrick Niaudet; Sevgi Mir; Aysin Bakkaloglu; Barbara Enke; Giovanni Montini; Ann-Margret Wingen; Peter Sallay; Nikola Jeck; Ulla Berg; Salim Caliskan; Simone Wygoda; Katharina Hohbach-Hohenfellner; Jiri Dusek; Tomasz Urasinski; Klaus Arbeiter; Thomas Neuhaus; Jutta Gellermann; Dorota Drozdz; Michel Fischbach; Kristina Möller; Marianne Wigger; Licia Peruzzi; Otto Mehls; Franz Schaefer
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

View more
  10 in total

1.  Is it time for a multi-specialty approach to cardio-renal dysfunction in children with cyanotic congenital heart disease?

Authors:  Tanya Holt; Guido Filler
Journal:  Pediatr Nephrol       Date:  2017-10-02       Impact factor: 3.714

Review 2.  New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management.

Authors:  Wendy L St Peter; Lori D Wazny; Uptal D Patel
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-11       Impact factor: 2.894

Review 3.  Adding Life to Their Years: The Current State of Pediatric Palliative Care in CKD.

Authors:  Taylor R House; Aaron Wightman
Journal:  Kidney360       Date:  2021-04-07

4.  Reliable individualized monitoring improves cholesterol control in kidney transplant recipients.

Authors:  David K Hooper; Cassie L Kirby; Peter A Margolis; Jens Goebel
Journal:  Pediatrics       Date:  2013-03-11       Impact factor: 7.124

5.  Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry.

Authors:  Ahmad Kaddourah; Stuart L Goldstein; Steven E Lipshultz; James D Wilkinson; Lynn A Sleeper; Minmin Lu; Steven D Colan; Jeffrey A Towbin; Scott I Aydin; Joseph Rossano; Melanie D Everitt; Jeffrey G Gossett; Paolo Rusconi; Paul F Kantor; Rakesh K Singh; John L Jefferies
Journal:  Pediatr Nephrol       Date:  2015-07-26       Impact factor: 3.714

6.  Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease.

Authors:  Nattaphorn Hongsawong; Prapimdaw Khamdee; Suchaya Silvilairat; Wattana Chartapisak
Journal:  Pediatr Nephrol       Date:  2017-10-02       Impact factor: 3.714

7.  Factors influencing choice of renal replacement therapy in European paediatric nephrology units.

Authors:  Alan R Watson; Wesley N Hayes; Karel Vondrak; Gema Ariceta; Claus Peter Schmitt; Mesiha Ekim; Michel Fischbach; Alberto Edefonti; Rukshana Shroff; Tuula Holta; Aleksandra Zurowska; Gunter Klaus; Sevan Bakkaloglu; Constantinos J Stefanidis; Constantinos Stefanidos; Johan Van de Walle
Journal:  Pediatr Nephrol       Date:  2013-07-11       Impact factor: 3.714

8.  Factors associated with the absence of pharmacological treatment for common modifiable complications in children with chronic kidney disease.

Authors:  Yunwen Xu; Derek K Ng; Susan L Furth; Bradley A Warady; Mark M Mitsnefes
Journal:  Pediatr Nephrol       Date:  2021-05-06       Impact factor: 3.714

9.  Prevalence and predictors of aortic dilation as a novel cardiovascular complication in children with end-stage renal disease.

Authors:  Ahmad Kaddourah; Susan Uthup; Peace Madueme; Matthew O'Rourke; David K Hooper; Michael D Taylor; Steven D Colan; John L Jefferies; Marepalli B Rao; Jens Goebel
Journal:  Clin Nephrol       Date:  2015-05       Impact factor: 0.975

10.  No association between cyclosporine levels and dyslipidemia?

Authors:  Guido Filler
Journal:  Nephrourol Mon       Date:  2014-01-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.